Revance Therapeutics Inc (NASDAQ:RVNC)
| 12.24 Delayed Data As of 4:00pm ET |  -0.54 / -4.23%Today’s Change | 11.65 Today|||52-Week Range 33.83 | -25.00% Year-to-Date |
Latest RVNC News | Press Releases
No recent news for Revance Therapeutics Inc.
Today’s Trading
| Previous close | 12.78 |
| Today’s open | 12.74 |
| Day’s range | 12.06 - 12.80 |
| Volume | 84,285 |
| Average volume (3 months) | 701,794 |
| Market cap | $1.0B |
Data as of 4:00pm ET, 05/25/2022
Growth & Valuation
| Earnings growth (last year) | +14.31% |
| Earnings growth (this year) | +9.72% |
| Earnings growth (next 5 years) | +192.00% |
| Revenue growth (last year) | +407.65% |
| P/E ratio | NM |
| Price/Sales | 14.16 |
| Price/Book | 14.34 |
Competitors
Data as of 4:00pm ET, 05/25/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.81 |
| Annual revenue (last year) | $77.8M |
| Annual profit (last year) | -$281.3M |
| Net profit margin | -361.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Nashville, Tennessee |
Forecasts
